Jan 22, 2024 - News

Ohio's southern neighbors are hot spots for anti-obesity drugs

Rate of GLP-1 prescriptions dispensed to patients
Data:Ā PurpleLab HealthNexus database; Map: Axios Visuals

Ohio's southern neighbors had the highest prescription rates for a buzzy class of diabetes and anti-obesity medications last year

  • That's according to insurance claims data provided to Axios by health analytics company PurpleLab.

What's happening: Kentucky and West Virginia were among the states with high prescribing rates for drugs like Ozempic and Wegovy.

  • Ohio had the ninth-most prescriptions overall, at 8.5 per 1,000 residents.

By the numbers: Kentucky's 21 prescriptions per 1,000 residents paced the field.

  • West Virginia was close behind, with 18.9 prescriptions dispensed per 1,000.

The big picture: The data offers a snapshot of where drugs known as GLP-1 agonists, seen as game-changers in the fight against obesity, are most in demand in the United States.

  • The states with the highest prescribing rates are also among those with greater prevalence of diabetes and obesity, per CDC data.

Go deeper: The United States of Ozempic

avatar

Get more local stories in your inbox with Axios Cleveland.

šŸŒ±

Support local journalism by becoming a member.

Learn more

More Cleveland stories

No stories could be found

Clevelandpostcard

Get a free daily digest of the most important news in your backyard with Axios Cleveland.

šŸŒ±

Support local journalism by becoming a member.

Learn more